Takagi, Satoshi
Miura, Junnosuke http://orcid.org/0000-0002-5115-1111
Shimura, Kanako
Hoshina, Sari
Tsuchida, Yukiko
Takita, Mikako
Mochizuki, Shota
Shen, Zhuo
Asanuma, Takuya
Takaike, Hiroko
Babazono, Tetsuya
Article History
Received: 30 April 2021
Accepted: 23 August 2021
First Online: 2 September 2021
Declarations
:
: TB is supported through unrestricted research funding: Novartis Pharma KK, Eli Lilly Japan K.K., Honoraria (e. g. lecture fees): Novo Nordisk Pharma Ltd., MSD K.K., Takeda Pharmaceutical Company Limited, Taisho Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., and Subsidies or Donations: Terumo Corporation, TEIJIN PHARMA LIMITED, Abbott Japan LLC, Sumitomo Dainippon Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Baxter Limited, Alcon Japan Ltd., Chugai Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., NIPRO CORPORATION, MSD K.K., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co., Ltd., Taisho Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd, Santen Pharmaceutical Co., Ltd., SANWA KAGAKU KENKYUSHO CO., LTD.. ST, JM, KS, SH, YT, MT, SM, ZS, TA, and HK declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (the ethics committee of Tokyo Women’s Medical University; approval number 181203; date of approval, December 7, 2018) and with the Helsinki Declaration of 1964 and later versions. Written informed consent were obtained from all subjects prior to enrollment in the study.